314 related articles for article (PubMed ID: 28453784)
1. Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients.
Figueroa JM; Skog J; Akers J; Li H; Komotar R; Jensen R; Ringel F; Yang I; Kalkanis S; Thompson R; LoGuidice L; Berghoff E; Parsa A; Liau L; Curry W; Cahill D; Bettegowda C; Lang FF; Chiocca EA; Henson J; Kim R; Breakefield X; Chen C; Messer K; Hochberg F; Carter BS
Neuro Oncol; 2017 Oct; 19(11):1494-1502. PubMed ID: 28453784
[TBL] [Abstract][Full Text] [Related]
2. In vivo evaluation of EGFRvIII mutation in primary glioblastoma patients via complex multiparametric MRI signature.
Akbari H; Bakas S; Pisapia JM; Nasrallah MP; Rozycki M; Martinez-Lage M; Morrissette JJD; Dahmane N; O'Rourke DM; Davatzikos C
Neuro Oncol; 2018 Jul; 20(8):1068-1079. PubMed ID: 29617843
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral thrombosis as a histological biomarker for predicting epidermal growth factor receptor alteration and poor prognosis in patients with glioblastomas.
Furuta T; Negoto T; Miyoshi H; Moritsubo M; Nakamura H; Morioka M; Akiba J; Ohshima K; Sugita Y
J Neurooncol; 2023 Sep; 164(3):633-641. PubMed ID: 37710025
[TBL] [Abstract][Full Text] [Related]
4. Large and small extracellular vesicles released by glioma cells
Yekula A; Minciacchi VR; Morello M; Shao H; Park Y; Zhang X; Muralidharan K; Freeman MR; Weissleder R; Lee H; Carter B; Breakefield XO; Di Vizio D; Balaj L
J Extracell Vesicles; 2020; 9(1):1689784. PubMed ID: 31839905
[TBL] [Abstract][Full Text] [Related]
5. Self-Functionalized Superlattice Nanosensor Enables Glioblastoma Diagnosis Using Liquid Biopsy.
Premachandran S; Haldavnekar R; Ganesh S; Das S; Venkatakrishnan K; Tan B
ACS Nano; 2023 Oct; 17(20):19832-19852. PubMed ID: 37824714
[TBL] [Abstract][Full Text] [Related]
6. Correlation between EGFR amplification and the expression of microRNA-200c in primary glioblastoma multiforme.
Serna E; Lopez-Gines C; Monleon D; Muñoz-Hidalgo L; Callaghan RC; Gil-Benso R; Martinetto H; Gregori-Romero A; Gonzalez-Darder J; Cerda-Nicolas M
PLoS One; 2014; 9(7):e102927. PubMed ID: 25058589
[TBL] [Abstract][Full Text] [Related]
7. EGFRvIII expression triggers a metabolic dependency and therapeutic vulnerability sensitive to autophagy inhibition.
Jutten B; Keulers TG; Peeters HJM; Schaaf MBE; Savelkouls KGM; Compter I; Clarijs R; Schijns OEMG; Ackermans L; Teernstra OPM; Zonneveld MI; Colaris RME; Dubois L; Vooijs MA; Bussink J; Sotelo J; Theys J; Lammering G; Rouschop KMA
Autophagy; 2018; 14(2):283-295. PubMed ID: 29377763
[TBL] [Abstract][Full Text] [Related]
8. Proteome profiling of salivary small extracellular vesicles in glioblastoma patients.
Müller Bark J; Trevisan França de Lima L; Zhang X; Broszczak D; Leo PJ; Jeffree RL; Chua B; Day BW; Punyadeera C
Cancer; 2023 Sep; 129(18):2836-2847. PubMed ID: 37254878
[TBL] [Abstract][Full Text] [Related]
9. Cell-derived extracellular vesicles can be used as a biomarker reservoir for glioblastoma tumor subtyping.
Lane R; Simon T; Vintu M; Solkin B; Koch B; Stewart N; Benstead-Hume G; Pearl FMG; Critchley G; Stebbing J; Giamas G
Commun Biol; 2019; 2():315. PubMed ID: 31453379
[TBL] [Abstract][Full Text] [Related]
10. Bio-Inspired NanoVilli Chips for Enhanced Capture of Tumor-Derived Extracellular Vesicles: Toward Non-Invasive Detection of Gene Alterations in Non-Small Cell Lung Cancer.
Dong J; Zhang RY; Sun N; Smalley M; Wu Z; Zhou A; Chou SJ; Jan YJ; Yang P; Bao L; Qi D; Tang X; Tseng P; Hua Y; Xu D; Kao R; Meng M; Zheng X; Liu Y; Vagner T; Chai X; Zhou D; Li M; Chiou SH; Zheng G; Di Vizio D; Agopian VG; Posadas E; Jonas SJ; Ju SP; Weiss PS; Zhao M; Tseng HR; Zhu Y
ACS Appl Mater Interfaces; 2019 Apr; 11(15):13973-13983. PubMed ID: 30892008
[TBL] [Abstract][Full Text] [Related]
11. A novel EGFR variant EGFRx maintains glioblastoma stem cells through STAT5.
Huang W; Li J; Zhu H; Qin X; Chen C; Wang B; Wei J; Song Y; Lu X; Li Z; Xia W; He A; Cheng L; Yu X; Shu K; Wang W
Neuro Oncol; 2024 Jan; 26(1):85-99. PubMed ID: 37616578
[TBL] [Abstract][Full Text] [Related]
12. Extracellular vesicles from genetically unstable, oncogene-driven cancer cells trigger micronuclei formation in endothelial cells.
Chennakrishnaiah S; Tsering T; Gregory C; Tawil N; Spinelli C; Montermini L; Karatzas N; Aprikian S; Choi D; Klewes L; Mai S; Rak J
Sci Rep; 2020 May; 10(1):8532. PubMed ID: 32444772
[TBL] [Abstract][Full Text] [Related]
13. MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development.
Akers JC; Ramakrishnan V; Kim R; Skog J; Nakano I; Pingle S; Kalinina J; Hua W; Kesari S; Mao Y; Breakefield XO; Hochberg FH; Van Meir EG; Carter BS; Chen CC
PLoS One; 2013; 8(10):e78115. PubMed ID: 24205116
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal analysis of serum-derived extracellular vesicle RNA to monitor dacomitinib treatment response in EGFR-amplified recurrent glioblastoma patients.
Yekula A; Hsia T; Kitchen RR; Chakrabortty SK; Yu W; Batool SM; Lewis B; Szeglowski AJ; Weissleder R; Lee H; Chi AS; Batchelor T; Carter BS; Breakefield XO; Skog J; Balaj L
Neurooncol Adv; 2023; 5(1):vdad104. PubMed ID: 37811539
[TBL] [Abstract][Full Text] [Related]
15. Advancements and Technical Considerations for Extracellular Vesicle Isolation and Biomarker Identification in Glioblastoma.
Cumba Garcia LM; Bouchal SM; Bauman MMJ; Parney IF
Neurosurgery; 2023 Jul; 93(1):33-42. PubMed ID: 36749103
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal glioma stem cells trigger vasectasia-distinct neovascularization process stimulated by extracellular vesicles carrying EGFR.
Spinelli C; Adnani L; Meehan B; Montermini L; Huang S; Kim M; Nishimura T; Croul SE; Nakano I; Riazalhosseini Y; Rak J
Nat Commun; 2024 Apr; 15(1):2865. PubMed ID: 38570528
[TBL] [Abstract][Full Text] [Related]
17. An integrated genomic analysis of human glioblastoma multiforme.
Parsons DW; Jones S; Zhang X; Lin JC; Leary RJ; Angenendt P; Mankoo P; Carter H; Siu IM; Gallia GL; Olivi A; McLendon R; Rasheed BA; Keir S; Nikolskaya T; Nikolsky Y; Busam DA; Tekleab H; Diaz LA; Hartigan J; Smith DR; Strausberg RL; Marie SK; Shinjo SM; Yan H; Riggins GJ; Bigner DD; Karchin R; Papadopoulos N; Parmigiani G; Vogelstein B; Velculescu VE; Kinzler KW
Science; 2008 Sep; 321(5897):1807-12. PubMed ID: 18772396
[TBL] [Abstract][Full Text] [Related]
18. Breaking through the glioblastoma micro-environment via extracellular vesicles.
Simon T; Jackson E; Giamas G
Oncogene; 2020 Jun; 39(23):4477-4490. PubMed ID: 32366909
[TBL] [Abstract][Full Text] [Related]
19. Extracellular Vesicles in Glioblastoma Tumor Microenvironment.
Yekula A; Yekula A; Muralidharan K; Kang K; Carter BS; Balaj L
Front Immunol; 2019; 10():3137. PubMed ID: 32038644
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma.
Sampson JH; Archer GE; Mitchell DA; Heimberger AB; Bigner DD
Semin Immunol; 2008 Oct; 20(5):267-75. PubMed ID: 18539480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
